Lobectomy for metachronous lung cancer after pneumonectomy
Pierre‐Emmanuel Falcoz, Jalal Assouad, Françoise Le Pimpec‐Barthes, Marc Riquet
Abstract
Open-access reader
Pierre‐Emmanuel Falcoz, Jalal Assouad, Françoise Le Pimpec‐Barthes, Marc Riquet
Abstract
Open-access reader
Second primary non-small cell lung cancer (NSCLC) is a well-known disease in patients having undergone successful NSCLC resection. Surgery for patients with cancer in the residual lung after pneumonectomy should not be excluded automatically. However, surgery on a single residual lung is usually done by wedge resection or segmentectomy, whereas lobectomy remains somewhat exceptional. We report the cases of two right upper lobectomy patients, alive and doing well at 5- and 6-year follow-up, with a FEV1 equal to 36% and 35% of predicted value, respectively.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Second primary non-small cell lung cancer (NSCLC) is a well-known disease in patients having undergone successful NSCLC resection. Surgery for patients with cancer in the residual lung after pneumonectomy should not be excluded automatically. However, surgery on a single residual lung is usually done by wedge resection or segmentectomy, whereas lobectomy remains somewhat exceptional. We report the cases of two right upper lobectomy patients, alive and doing well at 5- and 6-year follow-up, with a FEV1 equal to 36% and 35% of predicted value, respectively.
Key concepts: Pneumonectomy, Medicine, Wedge resection, Lung cancer, Surgery, Lung, Resection, Stage (stratigraphy)